Cancer Derived Organoids for Drug Discovery in Liver Cancers

Part of the Surgical Grand Rounds Series - Florin M. Selaru, MD identifies the utility and limitations of using patient derived organoids for drug screening in liver cancers.

Created by

Johns Hopkins Greater Washington Area

Related Presenters

Florin Selaru, MD

Florin Selaru, MD

Director, Meyerhoff Inflammatory Bowel Disease Center
Associate Professor of Medicine

Dr. Selaru is currently an Associate Professor of Medicine and Oncology, Division of Gastroenterology and Hepatology and Sidney Kimmel Cancer Center, Johns Hopkins University. He is also a member of the Institute of Nanobiotechnology at ...

View full profile